PathoNostics was founded in 2011 in Maastricht, The Netherlands and became an important player in the fungal diagnostic field. PathoNostics is focussing on the development and commercialization of real-time PCR kits for the diagnosis of superficial and invasive fungal infections. PathoNostics currently has four products on the market: AsperGenius®, DermaGenius®, PneumoGenius® and MucorGenius®.
PCR kits from PathoNostics enable a rapid and accurate diagnosis, leading to timely initiation of targeted therapy. The proprietary technology platform uses real-time PCR and melting curve analysis to detect and differentiate pathogens and identify resistance markers.